<DOC>
<DOCNO>EP-0638574</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Oxime derivatives of cephalosporanic structure and compounds for their preparation.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31435	A61K31435	A61K31535	A61K31535	A61K31545	A61K31545	A61K31546	A61K31546	A61P3100	A61P3104	C07C5900	C07C5970	C07C22900	C07C22934	C07C25100	C07C25116	C07C25124	C07C25140	C07C25148	C07C25152	C07C25160	C07C25500	C07C25513	C07C30700	C07C30702	C07C31100	C07C31108	C07C31700	C07C31744	C07C32300	C07C32362	C07D21300	C07D21363	C07D21374	C07D46300	C07D46300	C07D50100	C07D50100	C07D50118	C07D50120	C07D50122	C07D50124	C07D50126	C07D50130	C07D50136	C07D50138	C07D50140	C07D50148	C07D50150	C07D50159	C07D50160	C07D50500	C07D50500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P31	A61P31	C07C59	C07C59	C07C229	C07C229	C07C251	C07C251	C07C251	C07C251	C07C251	C07C251	C07C251	C07C255	C07C255	C07C307	C07C307	C07C311	C07C311	C07C317	C07C317	C07C323	C07C323	C07D213	C07D213	C07D213	C07D463	C07D463	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D501	C07D505	C07D505	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to oxime derivatives of cephalosporanic 
structure, possessing antibacterial activity of the following formula: 


where X, Y, Z, A, n, R and R₁ are as specified in the 
description. 
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
ACS DOBFAR SPA
</APPLICANT-NAME>
<APPLICANT-NAME>
ACS DOBFAR S.P.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
COLOMBO RICCARDO
</INVENTOR-NAME>
<INVENTOR-NAME>
LEONE MARIO
</INVENTOR-NAME>
<INVENTOR-NAME>
ZENONI MAURIZIO
</INVENTOR-NAME>
<INVENTOR-NAME>
COLOMBO, RICCARDO
</INVENTOR-NAME>
<INVENTOR-NAME>
LEONE, MARIO
</INVENTOR-NAME>
<INVENTOR-NAME>
ZENONI, MAURIZIO
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
This invention relates to oxime derivatives of cephalosporanic 
structure of formula (I) possessing antibacterial activity: 
where the meanings of the various radicals and substituents are 
chosen from the following groups:
 
X = absent, -O-, -S-, -SO-, -SO₂-, -NH-
 
Y = -CH, N-
 
Z = -H, halogen, -OH, C₁-C₅ O-alkyl, -OCH₂CONH₂, -OCONH₂,
 
-OSO₂NH₂, -OCH₂CN, -NH₂ either as such or substituted with C₁-C₆ 
alkyl radicals, -NHCOCH₃, -NHSO₂CH₃, 
amides of 
C₁-C₄ linear acids, amides of benzene and toluene derivatives, 
-NO₂, -NO, -CHO, -CH₂OH, -COOH, -SH, -SOH, -SO₂H, -SO₃H, -S-alkyl 
where the alkyl residue is C₁-C₃, -CF₃
 
R: -H, -OH, C₁-C₅ -O-alkyl with the alkyl residue possibly  
 
containing halogens, acid functionalities either free or salified 
with alkaline or alkaline earth metals, basic functions such as - 
OCH₂CH₂NH₂, -OCH₂CH₂NH-CH₃, -OCH₂(o, m, p)-pyridinyl, -OCH₂CN, - 
OCH₂CONH₂, -OCH₂SO₂NH₂;
 
n = 0 to 4
 
A = -S-, -O-, -CH₂- , -SO-, SO₂- ;
 
R₁ = a structural group characteristic of cephalosporins, such as 
-Cl, -H, -OCH₃, -CH₂OCH₂NH₂, -CH₂OCH₃, -CH₃, -CH=CH-CH₃, -CF₃, -CO₂R₂, 
-SO₂R where R₂ is an alkyl or aryl radical 
their pharmaceutically acceptable salts and their C₆ and C₇ 
epimers.  The oxime configuration can be either (E) or (Z), preferably (E), 
analogous with the structures already known in the specific 
literature of the sector. The configuration of the 
cephalosporanic nucleus is identical to already known structures. The oxime derivatives of cephalosporanic structure according to 
the present invention possess the usual characteristics of 
cephalosporin analogues and are suitable for both oral and 
parenteral administration. In particular, in view of their 
spectrum of action, they are structurally comparable with both aminothiazole 
cephalosporins (cefotaxime, ceftizoxime, cefmenoxime, ceftriaxone, 
ceftazidime) and with those (cefuroxime) containing an oxime group 
able to increase their activity against β-lactamase producer 
bacteria. In addition because of the proximity of a substituent 
in the ortho position in the phenylacetic structure, there is 
similarity with ceforanide. Molecular mechanics studies have 
shown these analogies, which were then confirmed by studies 
effected in vitro on numerous bacterial strains. These new molecules can be considered structurally to consist of 
two parts: "cephalosporanic nuclei" of formula (II) 
(all well known in the literature for their use in the main 
cephalosporanic derivatives of first, second, third or more recent 
generation),
</DESCRIPTION>
<CLAIMS>
Oxime derivatives of cephalosporanic structure of formula 
(I) possessing antibacterial activity: 

 
where the meanings of the various radicals and substituents are 

chosen from the following groups: 
X = absent, -O-, -S-, -SO-, -SO₂-, -NH- 

Y: -CH, N- 
Z: -H, halogen, -OH, C₁-C₅ O-alkyl, -OCH₂CONH₂, -OCONH₂, 

-OSO₂NH₂, -OCH₂CN, -NH₂ either as such or substituted with C₁-C₆ 
alkyl radicals, -NHCOCH₃, -NHSO₂CH₃, 

 
amides of 

C₁-C₄ linear acids, amides of benzene and toluene derivatives, 
-NO₂, -NO, -CHO, -CH₂OH, -COOH, -SH, -SOH, -SO₂H, -SO₃H, -S-alkyl 

where the alkyl residue is C₁-C₃, -CF₃; 
R: -H, -OH, C₁-C₅ -O-alkyl with the alkyl residue possibly 

containing halogens, acid functionalities either free or salified 
with alkaline or alkaline earth metals, basic functions such as 

-OCH₂CH₂NH₂, -OCH₂CH₂NH-CH₃, -OCH₂(o, m, p)-pyridinyl, -OCH₂CN, 
-OCH₂CONH₂, -OCH₂SO₂NH₂; 

n = 0 to 4 
A = -S-, -O-, -CH₂-, -SO-, -SO₂- 

R₁ = a structural group characteristic of cephalosporins, such as 
-Cl, -H, -OCH₃, -CH₂OCH₂NH₂, -CH₂OCH₃, -CH₃, -CH=CH-CH₃, - CF₃, -CO₂R₂ , 

-SO₂R₂ where R₂ is an alkyl or aryl radical,  
their pharmaceutically acceptable salts and their C₆ and C₇ 

epimers. 
A process for preparing the oxime derivatives of 
cephalosporanic structure of formula (I), characterised by 

condensing a cephalosporanic nucleus of formula (II) 

 

with an ortho-oxime group of phenyl-, phenylthio- or phenoxyacetic 

acid of formula (III): 
 

the meanings of X, Y, Z, A, n, R and R₁ being as specified in 
claim 1. 
Ortho-oxime groups of phenyl-, phenylthio- and 
phenoxyacetic acids of formula (III): 

 
where X, Y, Z, A, n, R and R₁ are as specified in claim 1. 
</CLAIMS>
</TEXT>
</DOC>
